Related Experiment Videos
Mutation and expression of TP53 in malignant melanomas
1Department of Dermatology, University of Heidelberg, Mannheim, Germany.
Summary
TP53 gene mutations are common in cancer. In malignant melanoma, p53 protein overexpression occurred in 66% of tumors, but TP53 mutations were less frequent than in other skin cancers, suggesting UV damage plays a role.
Area of Science:
- Oncology
- Genetics
- Dermatology
Background:
- TP53 gene mutations are prevalent in human cancers.
- p53 protein overexpression is frequently observed in various skin cancers.
- The specific role of TP53 in malignant melanoma pathogenesis requires further elucidation.
Purpose of the Study:
- To investigate the expression and mutation status of the TP53 gene in malignant melanoma.
- To correlate p53 expression with clinicopathological features of melanoma.
- To explore the potential role of ultraviolet (UV) radiation in TP53 alterations in melanoma.
Main Methods:
- Immunohistochemistry was used to detect p53 protein expression in 145 primary and metastatic melanoma lesions and 12 cell lines.
- Nucleotide sequencing of the TP53 gene was performed on 24 melanoma samples.
- Analysis included correlation of p53 overexpression with tumor thickness and mutation patterns.
Main Results:
- p53 protein overexpression was detected in the cytoplasm of 66% of tumors and 93% of cell lines.
- TP53 gene mutations were identified in 7 out of 24 samples (approximately 29%), a lower frequency than in other skin tumors.
- Immunohistochemistry could not differentiate wild-type from mutant p53 overexpression.
- TP53 mutation patterns in most cases resembled UV-induced DNA damage.
Conclusions:
- TP53 alterations occur in a subset of malignant melanomas, with a frequency lower than in other skin cancers.
- UV light damage is implicated in the pathogenesis of a subgroup of melanomas.
- Further research is needed to understand the precise role of wild-type vs. mutant p53 in melanoma development and progression.